C4 Therapeutics, Inc.
Clinical trials sponsored by C4 Therapeutics, Inc., explained in plain language.
-
New combo tackles Hard-to-Treat myeloma
Disease control Recruiting nowThis early-stage trial is testing a new two-drug combination for people with multiple myeloma that has returned or stopped responding to prior treatments. The study will enroll about 60 participants to see if adding an oral drug called cemsidomide to an injectable antibody called…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New hope for Hard-to-Treat myeloma: experimental combo enters phase 2
Disease control Recruiting nowThis study tests a new drug, cemsidomide, combined with dexamethasone in people with multiple myeloma that has returned or not responded to at least three prior treatments. About 100 adults will receive the drug combo to see if it shrinks tumors and how safe it is. The goal is to…
Phase: PHASE2 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC